The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway

Linwei Jia, Yaohui Tian, Yonghan Chen, Gang Zhang

Open source

DOI
10.2147/ott.s154339
Published
2018-01
Container
OncoTargets and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s154339,
  title = {The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/\β-Catenin pathway},
  author = {Linwei Jia and Yaohui Tian and Yonghan Chen and Gang Zhang},
  year = {2018},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s154339},
  url = {https://doi.org/10.2147/ott.s154339}
}

RIS

TY  - JOUR
TI  - The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway
AU  - Linwei Jia
AU  - Yaohui Tian
AU  - Yonghan Chen
AU  - Gang Zhang
PY  - 2018
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s154339
UR  - https://doi.org/10.2147/ott.s154339
ER  - 

APA

Jia, L., Tian, Y., Chen, Y., & Zhang, G. (2018). The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway. OncoTargets and Therapy. https://doi.org/10.2147/ott.s154339

Source records